Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COMPARISON OF EFFICACY OF TWO IMMUNIZATION SCHEDULES (3 VS 4 DOSES) WITH RECOMBINANT HEP B VACCINE IN PATIENTS ON MAINTENANCE HEMODIALYSIS (MHD)

NCT07784452 is registered in ClinicalTrials.gov with Jinnah Hospital as lead sponsor.

NCT NCT07784452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07784452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COMPARISON OF EFFICACY OF TWO IMMUNIZATION SCHEDULES (3 VS 4 DOSES) WITH RECOMBINANT HEP B VACCINE IN PATIENTS ON MAINTENANCE HEMODIALYSIS (MHD)
Lead sponsor
Jinnah Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 10, 2025
Completion date
August 10, 2026
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic, esrd (end stage renal disease), hepatitis b, kidney failure